-
Study aim
-
The effectiveness of electrochemotherapy in the treatment of squamous cell cancers and sarcoma and the quality of life before and after treatment will be compared.
-
Design
-
clinical trial, 4 treatment groups of ECT with intravenous and intratumoral injection, non-random sampling, but allocation in treatment groups as random allocation. It is not possible to blind the patient and the researcher, but the coded checklists will be provided to the statistical consultant and the analysis will be presented based on the group name. Each group consists of 30 tumors.
-
Settings and conduct
-
After patient referral and drug selection, patients are randomly divided into intravenous and intratumoral injection groups, and treatment is carried out in two hospitals. In the intravenous group, pulses are applied 20 minutes after the treatment, and in the intratumoral group, applied 2 minutes after the injection of bleomycin. The application of the field will continue until the complete surface of the tumor is covered, and the number of repetitions depends on the volume of the tumor. The number of treatment sessions is three sessions.
-
Participants/Inclusion and exclusion criteria
-
Entry requirements:
The patient has the SCC or Sarcoma tumor.
Patients for whom standard treatments did not respond or did not have a positive effect.
Non-entry conditions:
The patient should have metal chips, platinum, and other metals within the scope of treatment.
-
Intervention groups
-
In this research, we examine and compare two treatment groups in two types of cancer, SCC and sarcoma.
Patient intervention includes:
1. Group of patients with intravenous injection of bleomycin
2. Group of patients with the intratumor injection of bleomycin
-
Main outcome variables
-
The results of the study will be reported in the form of tumor volume, analysis of quality of life and pain, as well as treatment efficiency.